Deal of the Day — limited-time pharmacy picks!
Bdenza 80mg capsule

Bdenza 80mg capsule

Prescription requiredRx Required

Salt Composition: Enzalutamide

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

14 Capsule(s) In A Strip

About The Product

Prostate Cancer

    Bdenza 80 mg capsule is a prescription-based medication. Enzalutamide, an androgen receptor inhibitor classified as an antineoplastic medication, is the active ingredient in the capsule. This capsule should only be used by men; women should not use it without gloves, especially if they are pregnant.

Uses

Advanced prostate cancer

Side Effects

  • It is advised to use Bdenza 80 mg capsule as directed by the doctor.
  • The common side effects of this tablet are: Trouble breathing (pneumonia) feeling tired Back pain diarrhoea cold headache insomnia high blood pressure swelling in arms, legs, feet, or hand

How To Use

  • It is advised to use Bdenza 80 mg capsule as directed by the doctor.
  • The common side effects of this tablet are: Trouble breathing (pneumonia) feeling tired Back pain diarrhoea cold headache insomnia high blood pressure swelling in arms, legs, feet, or hand

How It Works

Bdenza 80 mg capsules should always be taken as prescribed by a doctor; they are not meant for self-medication. It can be taken with or without food as directed by the doctor.

For optimal medication effectiveness, Bdenza 80 mg capsules must be swallowed rather than chewed, opened, or crushed. It is an oral medication used once a day at the same time every day, before meals.

The Bdenza 80 mg capsule should be taken with at least an hour gap interval.

Safety Advice

Alcohol
Drinking too much alcohol could harm a person's immunity and liver function. It is recommended not to drink alcohol while using Bdenza 80 mg capsules because it can cause fatigue, dizziness, confusion, and cognitive impairment.
Pregnancy
Because the Bdenza 80 mg capsule affects the fetus, it is not recommended to consume it while pregnant. Women should not use this remedy.
Breast Feeding
It is not recommended to take the Bdenza 80 mg capsule while nursing because there is a chance that it could be passed to the growing baby through the mother's breast milk. It is generally considered hazardous, but there is insufficient clinical proof to support its detrimental effects on newborns.
Driving
Taking a Bdenza 80 mg capsule while operating machinery may make it difficult to drive or cause confusion. Neurological adverse effects, like fever or lightheadedness, could result from the medication. Until you feel better, don't drive.
Kidney
After speaking with a doctor, those with renal problems can take the Bdenza 80mg tablet, but it requires dose adjustment. If used for self-medication, it could damage the kidneys.
Liver
Bdenza 80 mg capsules should not be taken by anyone who has a serious liver condition. On the other hand, this capsule can be used by those with minor liver illness, but it needs to be closely watched. Take care and adjust the Bdenza 80 mg capsule dosage as directed by your physician.

FAQs

As soon as you remember, take the missed dose unless it's time for your next dose.

You should never take a double dose to make up for a missed one.

Reference

Akaza, H., Uemura, H., Tsukamoto, T., Ozono, S., Ogawa, O., Sakai, H., & Naito, S. (2024).

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer. International Journal of Clinical Oncology, 21(4), 773-782.

Golshayan, A. R., & Antonarakis, E.

S. (2023).

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer. Core evidence, 27-35.

Hori, A., Sahashi, H., Sano, S., Matsumiya, E., Ariga, M., Asano, A., & Kitaichi, K. (2020).

Efficacy and safety of enzalutamide in a real-world cohort of Japanese patients with castration-resistant prostate cancer. Anticancer Research, 40(12), 7101-7108.

Miura, R., Hirabatake, M., Irie, K., Ikesue, H., Muroi, N., Kawakita, M., & Hashida, T. (2021).

Safety evaluation of enzalutamide dose-escalation strategy in patients with castration-resistant prostate cancer. In Urologic Oncology: Seminars and Original Investigations (Vol.

39, No. 4, pp.

233-e15). Elsevier.

Vinh-Hung, V., Natchagande, G., Joachim, C., Gorobets, O., Drame, M., Bougas, S. & Yin, M. (2020).

Low-dose enzalutamide in late-elderly patients (≥ 75 years old) presenting with metastatic castration-resistant prostate cancer. Clinical genitourinary cancer, 18(6), e660-e668.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026